Aurinia Pharmaceuticals Inc (AUPH) — Cash Flow Quality Index
Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow Quality Index of 0.95x as of March 2026. Operating cash flow of $32.56 Million is below net income of $34.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Aurinia Pharmaceuticals Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aurinia Pharmaceuticals Inc Cash Flow Quality Index (2024–2025)
Historical Cash Flow Quality Index for Aurinia Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Aurinia Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Aurinia Pharmaceuticals Inc (2024–2025)
Year-by-year earnings quality comparison for Aurinia Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is Aurinia Pharmaceuticals Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | $135.66 Million | $287.20 Million | ▼ -93.9% |
| 2024 | 7.72x | $44.39 Million | $5.75 Million | — |